The present invention relates to a highly pure oligosaccharide for use as an immunostimulant, to a pharmaceutical composition comprising the highly pure oligosaccharide according to the invention, to the use in vitro of the highly pure oligosaccharide according to the invention for stimulating immune cells or for activating/binding the TLR2 receptor.